Gerald J. Yakatan, Ph.D.

Chairman, CEO & Founder

Prior to founding IriSys in 1996, Dr. Yakatan served as President & CEO of Avanir Pharmaceuticals where he was responsible


Robert Giannini, Ph.D.

Vice President & Chief Technical Officer

Dr. Giannini has more than 30 years of pharmaceutical industry experience. His breadth of knowledge includes


Jin Jean Wang, Ph.D.

Vice President, Quality Assurance and Quality Control

Dr. Wang joined IriSys in 2009. Her responsibilities include providing technical and quality guidance via directly overseeing


Louis Scotti

Vice President, Business Development

Mr. Scotti joined IriSys in 2015 after previously serving on its Board of Directors from 2007 until 2012. He has headed


Victoria Smith Karpinski

Director of Human Resources & Administration

Ms. Karpinski joined IriSys in 2014. During 2003-2013, she and her husband relocated to an island in the western Caribbean, and


Igor Nikoulin, Ph.D.

Director of Research & Development

Dr. Nikoulin has 14 years of academic and 16 years of drug discovery and development experience serving as a


Kevin Xie


Prior to joining IriSys in 2014, Mr. Xie held various management level positions during his 18 years in diverse industries including


Brooke Yakatan

Director of Quality Assurance & Regulatory Affairs

Mr. Brooke Yakatan joined IriSys in 2014. His Quality Assurance experience includes the overseeing and maintaining of cGMP